Daehan New Pharm Co. Ltd (054670) — Capital Reinvestment Ratio
Daehan New Pharm Co. Ltd (054670) has a Capital Reinvestment Ratio of 2.61x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩4.43 Billion) in capital expenditures (₩11.53 Billion). See Daehan New Pharm Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Daehan New Pharm Co. Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Daehan New Pharm Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Check 054670 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Daehan New Pharm Co. Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Daehan New Pharm Co. Ltd from 2011 to 2024. For live market cap and broader valuation context, see market value of Daehan New Pharm Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.81x | ₩18.95 Billion | ₩34.26 Billion | ▲ +128.8% |
| 2023 | 0.79x | ₩12.57 Billion | ₩9.93 Billion | ▲ +220.5% |
| 2022 | 0.25x | ₩14.25 Billion | ₩3.51 Billion | ▼ -61.3% |
| 2021 | 0.64x | ₩16.58 Billion | ₩10.55 Billion | ▼ -8.9% |
| 2020 | 0.70x | ₩13.55 Billion | ₩9.46 Billion | ▲ +76.2% |
| 2019 | 0.40x | ₩22.89 Billion | ₩9.08 Billion | ▲ +368.9% |
| 2018 | 0.08x | ₩20.47 Billion | ₩1.73 Billion | ▼ -83.8% |
| 2016 | 0.52x | ₩8.75 Billion | ₩4.57 Billion | ▲ +5.5% |
| 2015 | 0.50x | ₩7.80 Billion | ₩3.86 Billion | ▼ -25.9% |
| 2014 | 0.67x | ₩10.02 Billion | ₩6.69 Billion | ▼ -86.2% |
| 2012 | 4.83x | ₩256.82 Million | ₩1.24 Billion | ▲ +1269.7% |
| 2011 | 0.35x | ₩3.42 Billion | ₩1.20 Billion | — |